$203.12
0.80% yesterday
NYSE, Oct 15, 10:00 pm CET

IQVIA Stock price

$203.12
+17.15 9.22% 1M
+53.97 36.19% 6M
+6.61 3.36% YTD
-29.86 12.82% 1Y
+21.94 12.11% 3Y
+41.12 25.38% 5Y
+132.49 187.58% 10Y
+161.01 382.36% 20Y
NYSE, Closing price Wed, Oct 15 2025
-1.64 0.80%

Key metrics

Basic
Market capitalization
$34.8b
Enterprise Value
$48.1b
Net debt
$13.3b
Cash
$2.2b
Shares outstanding
170.0m
Valuation (TTM | estimate)
P/E
28.7 | 17.1
P/S
2.2 | 2.1
EV/Sales
3.1 | 2.9
EV/FCF
23.9
P/B
6.0
Financial Health
Equity Ratio
22.6%
Return on Equity
22.6%
ROCE
10.8%
ROIC
9.1%
Debt/Equity
2.7
Financials (TTM | estimate)
Revenue
$15.7b | $16.3b
EBITDA
$3.4b | $3.8b
EBIT
$2.3b | $3.1b
Net Income
$1.2b | $2.0b
Free Cash Flow
$2.0b
Growth (TTM | estimate)
Revenue
3.6% | 6.0%
EBITDA
4.3% | 12.8%
EBIT
7.9% | 35.5%
Net Income
-13.1% | 48.4%
Free Cash Flow
10.0%
Margin (TTM | estimate)
Gross
34.3%
EBITDA
21.6% | 23.4%
EBIT
14.4%
Net
7.9% | 12.5%
Free Cash Flow
12.8%
More
EPS
$7.1
FCF per Share
$11.8
Short interest
3.1%
Employees
88k
Rev per Employee
$180.0k
Show more

Is IQVIA a Top Scorer Stock based on the Dividend, High-Growth-Investing or Leverman Strategy?

As a Free StocksGuide user, you can view scores for all 7,003 stocks worldwide.

IQVIA Stock Analysis

Unlock Scores for Free

Analyst Opinions

29 Analysts have issued a IQVIA forecast:

22x Buy
76%
7x Hold
24%

Analyst Opinions

29 Analysts have issued a IQVIA forecast:

Buy
76%
Hold
24%

Financial data from IQVIA

Income Statement P&L | Balance Sheet | Cash Flow


Quarter TTM Annually
Jun '25
+/-
%
15,700 15,700
4% 4%
100%
- Direct Costs 10,323 10,323
5% 5%
66%
5,377 5,377
1% 1%
34%
- Selling and Administrative Expenses 1,992 1,992
4% 4%
13%
- Research and Development Expense - -
-
-
3,385 3,385
4% 4%
22%
- Depreciation and Amortization 1,122 1,122
2% 2%
7%
EBIT (Operating Income) EBIT 2,263 2,263
8% 8%
14%
Net Profit 1,237 1,237
13% 13%
8%

In millions USD.

Don't miss a Thing! We will send you all news about IQVIA directly to your mailbox free of charge.

If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.

IQVIA Stock News

Neutral
Business Wire
15 days ago
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, will announce its third-quarter 2025 financial results before the market opens on Tuesday, October 28, 2025. The IQVIA management team will also host a con...
Negative
Forbes
19 days ago
Amid increased competition from China's MGI Tech, Illumina's stock (NASDAQ: ILMN) has dropped by 11% in a week. MGI Tech's DNA sequencers are reportedly gaining market share, and despite a recent decline in its international sales due to U.S. sanctions, MGI Tech's global market presence remains strong.
Neutral
Business Wire
29 days ago
RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)--IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, has been honored with the WCG Pinnacle Award for Site Relationships in Professionalism and Communication. The award recognizes IQVIA's commitment to building strong, collaborative...
More IQVIA News

Company Profile

Provides biopharmaceutical development services and commercial outsourcing services

Head office United States
CEO Ari Bousbib
Employees 88,000
Founded 1950
Website ir.iqvia.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today